Table 2. t-test statistical table of features.
Features | AD patient(N=802) | Non-AD patient (N=52,411) | χ2/t | P |
---|---|---|---|---|
Age | 55.57±12.90 | 62.56±13.06 | 15.03 | <0.001 |
Sex | 574 (71.57%) | 29,994 (57.23%) | 66.47 | <0.001 |
Chest pain | 206 (25.79%) | 9,460 (18.05%) | 30.99 | <0.001 |
Stomachache | 66 (8.23%) | 2,996 (5.72%) | 9.2 | 0.002 |
Heart disease | 63 (7.86%) | 6,106 (11.65%) | 11.1 | 0.001 |
Dizziness and headache | 62 (7.73%) | 7,803 (14.89%) | 32.13 | <0.001 |
Aortic valve area murmur | 23 (2.87%) | 377 (0.72%) | 48.88 | <0.001 |
Family history of hypertension | 92 (11.47%) | 4,798 (9.15%) | 5.08 | 0.024 |
Chest trauma history | 11 (1.37%) | 206 (0.39%) | 18.62 | <0.001 |
Smoking and duration | 10.22±14.39 | 7.34±13.88 | −5.63 | <0.001 |
Hypertension | 530 (66.08%) | 31,571 (60.24%) | 11.29 | 0.001 |
Hypertension and duration | 6.01±6.47 | 6.10±7.09 | 0.36 | 0.72 |
Diabetes | 88 (10.97%) | 11,910 (22.72%) | 62.47 | <0.001 |
Diabetes and duration | 0.85±2.87 | 1.82±3.83 | 9.4 | <0.001 |
Heart rate | 81.74±13.87 | 78.73±14.20 | −6.1 | <0.001 |
Systolic pressure | 142.41±26.71 | 136.86±21.90 | −5.85 | <0.001 |
Diastolic pressure | 83.20±16.59 | 80.46±13.01 | −4.66 | <0.001 |
HGB | 119.76±21.57 | 119.95±22.47 | 0.24 | 0.814 |
NEUT | 7.16±4.08 | 4.79±3.47 | −16.35 | <0.001 |
NEUT% | 72.83±10.79 | 65.30±12.09 | −19.59 | <0.001 |
LYMPH% | 16.94±9.10 | 24.22±10.44 | 22.43 | <0.001 |
LYMPH | 1.36±0.60 | 1.57±2.03 | 9.07 | <0.001 |
MCV | 91.84±6.82 | 92.10±7.17 | 1.09 | 0.275 |
MPV | 8.93±1.39 | 9.36±1.58 | 8.6 | <0.001 |
TP | 64.58±7.06 | 65.43±8.04 | 3.41 | 0.001 |
ALB | 37.08±5.67 | 38.61±6.26 | 7.6 | <0.001 |
GLO | 27.57±5.19 | 26.94±5.32 | −3.39 | 0.001 |
A/G | 1.40±0.36 | 1.49±0.37 | 6.77 | <0.001 |
TBIL | 16.19±21.62 | 13.20±26.81 | −3.86 | <0.001 |
DBIL | 6.65±11.52 | 5.39±13.53 | −3.07 | 0.002 |
TBA | 6.22±13.32 | 7.55±15.04 | 2.49 | 0.013 |
ALT | 66.50±296.27 | 32.47±108.73 | −3.25 | 0.001 |
AST | 85.34±510.27 | 36.33±155.39 | −2.72 | 0.007 |
CRE | 136.87±156.07 | 138.98±213.75 | 0.28 | 0.781 |
GSP | 2.25±0.62 | 2.03±0.73 | −9.79 | <0.001 |
CHO | 4.33±0.43 | 4.37±0.55 | 2.19 | 0.029 |
HDL | 1.12±0.17 | 1.12±0.17 | 0.28 | 0.782 |
LDL | 2.60±0.35 | 2.63±0.46 | 1.98 | 0.048 |
LDH | 322.03±684.10 | 236.51±283.48 | −3.54 | <0.001 |
CK | 538.04±5272.64 | 162.57±567.45 | −2.02 | 0.044 |
CKMB | 35.93±299.32 | 19.33±33.08 | −1.57 | 0.117 |
MB | 72.69±84.95 | 57.60±59.02 | −5.01 | <0.001 |
K | 3.83±0.56 | 3.97±0.52 | 7.52 | <0.001 |
Na | 139.37±4.28 | 140.71±3.79 | 8.77 | <0.001 |
Cl | 101.08±4.95 | 102.59±4.62 | 8.56 | <0.001 |
CO2 | 23.14±3.21 | 23.20±3.65 | 0.51 | 0.609 |
AG | 15.23±3.68 | 14.95±3.35 | −2.38 | 0.017 |
Ca | 2.16±0.16 | 2.21±0.18 | 8.88 | <0.001 |
P | 1.19±0.39 | 1.19±0.34 | 0.55 | 0.581 |
Mg | 0.90±0.13 | 0.89±0.13 | −2.38 | 0.017 |
ESR | 34.94±10.81 | 35.40±13.92 | 1.17 | 0.241 |
PT% | 99.83±18.59 | 106.62±17.36 | 10.28 | <0.001 |
INR | 1.06±0.39 | 1.01±0.28 | −3.91 | <0.001 |
APTT | 37.66±11.29 | 35.54±9.68 | −5.29 | <0.001 |
FIB | 4.44±1.81 | 3.77±1.22 | −10.45 | <0.001 |
D-Dimer | 1.37±1.94 | 0.97±1.27 | −5.49 | <0.001 |
PLG | 252.01±24.57 | 255.86±27.68 | 4.4 | <0.001 |
TT | 18.92±14.17 | 19.11±12.91 | 0.4 | 0.691 |
PT | 13.57±4.39 | 13.02±3.06 | −3.58 | <0.001 |
ATAG | 271.19±17.23 | 271.18±21.52 | −0.01 | 0.99 |
FT3 | 3.91±0.44 | 3.96±1.15 | 3.33 | 0.001 |
TSH | 3.35±2.51 | 3.41±3.74 | 0.672 | 0.502 |
NEUT, neutrophils; LYMPH, lymphocytes; MCV, mean corpuscular volume; MPV, mean platelet volume; TP, total protein; ALB, albumin; GLO, globulin; A/G, ALB/GLO ratio; TBIL, total bilirubin; DBIL, direct bilirubin; TBA, total bile acid; ALT, alanine aminotransferase; AST, aspartate aminotransferase; CRE, creatinine; GSP, glycosylated serum protein; CHO, cholesterol; HDL, high-density lipoprotein; LDL, low-density lipoprotein; LDH, lactate dehydrogenase; CK, creatine kinase; ESR, erythrocyte sedimentation rate; PT, prothrombin time; INR, international normalised ratio; APTT, activated partial thromboplastin time; FIB, fibrinogen; TT, thrombin time; PT, prothrombin time; ATAG, antithrombin III antigen; FT3, free triiodothyronine-T3; TSH, thyroid-stimulating hormone.